With a trillion-dollar market cap and a wildly successful GLP-1 portfolio, Eli Lilly isn’t resting on its laurels. At the ...

Silver Spring, MD, Sept. 21, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued a direct final rule ...

With sales of the oral GLP-1 medicine rising quickly, executives reassured investors that Novo has secured production capacity to support continued growth.

As Big Pharma adds AI technology to bolster drug development, a cadre of new, upstart biotechs are pushing drug discovery to ...

The mid-stage readout is one link in a chain of catalysts that analysts were watching for this year from Roche’s metabolic pipeline, which features assets from the $2.7 billion acquisition of Carmot ...

With more than 25 companies debuting on the public markets, 2026 has recorded the highest number of biotech IPOs since 2021. Now, four companies—including Iambic Therapeutics and ADARx Pharmaceuticals ...

The awards are subject to all terms and conditions and other provisions set forth in the Company’s 2022 Inducement Equity ...

Rutika Mehta, MD, MPH, a nationally recognized gastrointestinal (GI) medical oncologist, has joined NYU Langone Health's ...

The Evident Ovarian Cancer Screening Test is powered by Mercy's patented Mercy Halo™ liquid biopsy platform, which uses ...

$12.5 million in support to build talent pipeline, workforce training center with San Jacinto College ...

Eric Dube, Ph.D., has decided to step down as President and Chief Executive Officer in December Following Eight Years of Exemplary Leadership SAN DIEGO-- (BUSINESS WIRE)-- $TVTX --Travere Therapeutics ...

Novo has “gone shopping” to fill pipeline gaps, with a focus on obesity and diabetes, plus an expansion in blood and endocrine disorders, liver diseases and cardiovascular conditions.